Greenberg et al. investigated the effects of several molecules on CKD progression, tubule health and inflammation, such as epidermal growth factor (EGF), α-1 microglobulin, KIM1 and monocyte chemoattractant protein-1 (MCP-1). This evidence concerns the gene CCL2 and chronic kidney disease.